☆Atlas Venture Life Science Advisors, LLC
Quality Q
0.872
AUM ($M)
881
Positions
7
Turnover
0.15
Top-10 wt
100%
Herfindahl
0.223
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 7 positions · portfolio value $881M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆KYMR funds › | Kymera Therapeutics, Inc. | TRIM | — | 37.1% | -11.2% | 326.5 | 2,847,541 | -1,730,467 | 5 | — |
| ☆DYN funds › | Dyne Therapeutics, Inc. | TRIM | — | 17.1% | -3.8% | 151.0 | 6,800,099 | -2,330,366 | 5 | — |
| ☆SION funds › | Sionna Therapeutics, Inc. | HOLD | — | 15.0% | -0.2% | 131.8 | 2,995,602 | +0 | 5 | — |
| ☆KLRA funds › | Kailera Therapeutics, Inc. | NEW | — | 12.9% | +12.9% | 113.9 | 5,171,282 | +5,171,282 | 1 | — |
| ☆IRON funds › | Disc Medicine, Inc. | HOLD | — | 12.6% | +0.3% | 110.7 | 1,513,875 | +0 | 5 | — |
| ☆QTTB funds › | Q32 Bio, Inc. | ADD | — | 3.9% | +2.2% | 34.6 | 2,717,106 | +625,000 | 5 | — |
| ☆KRRO funds › | Korro Bio, Inc. | TRIM | — | 1.4% | -0.2% | 12.7 | 962,884 | -174,265 | 5 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 881 | 7 | 0.15 | 100% | 0.223 | 0.871 | — | in |
| 2026Q1 | 790 | 6 | 0.09 | 100% | 0.316 | 0.918 | — | in |
| 2025Q4 | 865 | 8 | 0.12 | 100% | 0.263 | 0.883 | — | in |
| 2025Q3 | 753 | 9 | 0.17 | 100% | 0.223 | 0.823 | — | in |
| 2025Q2 | 662 | 11 | 0.15 | 100% | 0.184 | 0.851 | — | entered |
| 2025Q1 | 522 | 13 | 0.00 | 99% | 0.173 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status